It is not certain that the existence of such a fund prior to the recent Ebola outbreak would have led to the development of vaccines or treatments for the disease. But pharmaceutical companies would have been considering such products – as well as other treatments to save lives or improve health anywhere in the world, regardless of people’s ability to pay.
在最近的埃博拉爆发前存在这样一个基金是否能推动埃博拉疫苗和治手段的开发，我们无法确定。但制药公司将对这类产品有所考虑——其他在地球某处拯救生命、改善健康的治疗手段亦然，不管人们是否有支付能力。